Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump.
In This Article:
Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due to what Novo says is illegal compounding of GLP-1 medicines.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due to what Novo says is illegal compounding of GLP-1 medicines.